4//SEC Filing
KOENIG DAVID 4
Accession 0001179110-12-010778
CIK 0001222244other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 3:29 PM ET
Size
13.6 KB
Accession
0001179110-12-010778
Insider Transaction Report
Form 4
KOENIG DAVID
Director
Transactions
- Award
Common stock, $0.00001 par value
2012-06-20$1.00/sh+6,500$6,500→ 188,324 total
Holdings
- 26,571(indirect: Shares held by Clinical Network Inc., of which the reporting person is a managing officer.)
Common Stock, $0.00001 par value
- 50,000
Stock options
Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (50,000 underlying) - 50,000
Warrants
Exercise: $1.30Exp: 2013-08-02→ Common stock, $0.00001 par value (50,000 underlying) - 1,875(indirect: Shares held by Clinical Network Management Corp., of which reporting person is a managing officer.)
Common Stock, $0.00001 par value
- 14,535
Stock Options
Exercise: $1.72Exp: 2017-08-10→ Common stock, $0.00001 par value (14,535 underlying) Convertible Note
Exercise: $1.10Exp: 2012-08-28→ Common stock, $0.00001 par value- 28,736
Stock options
Exercise: $0.87Exp: 2018-08-09→ Common stock, $0.00001 par value (28,736 underlying)
Footnotes (4)
- [F1]Currently exercisable.
- [F2]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors at its annual shareholders' meeting on August 9, 2011. The seven-year options vest ratably over 12 months.
- [F3]On December 1, 2011, the reporting person and the Company executed a convertible promissory note in the principal amount of $6,400 with a maturity date of February 28, 2012. The maturity date was subsequently changed to August 28, 2012. The principal amount and interest accruing at a rate of 10% per year are convertible into common shares at $1.10 per share at any time through the maturity date. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rules 16b-3(d).
- [F4]Shares issued in lieu of cash for director's fees as approved by the Board of Directors which are exempt under section 16b-3(d).
Documents
Issuer
ProUroCare Medical Inc.
CIK 0001222244
Entity typeother
Related Parties
1- filerCIK 0001285927
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 3:29 PM ET
- Size
- 13.6 KB